Last10K.com

Sanofi (SNY) SEC Filing 20-F Annual report for the fiscal year ending Monday, December 31, 2018

Sanofi

CIK: 1121404 Ticker: SNY

View differences made from one year to another to evaluate Sanofi's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Sanofi.

Continue

Assess how Sanofi's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Sanofi's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Income Statements
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (Parenthetical)
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Changes In Equity (Parenthetical)
Consolidated Statements Of Comprehensive Income
Accounts Receivable
Accounts Receivable (Tables)
Accounts Receivable - Additional Information (Detail)
Accounts Receivable - Additional Information (Parenthetical) (Detail)
Accounts Receivable - Summary Of Accounts Receivable (Detail)
Accounts Receivable - Summary Of Gross Value Of Overdue Receivables (Detail)
Alliance Arrangements With Bristol-Myers Squibb (Bms) - Additional Information (Detail)
Alliance Arrangements With Regeneron Pharmaceuticals, Inc. (Regeneron) - Antibodies Collaboration Agreement - Additional Information (Detail)
Alliance Arrangements With Regeneron Pharmaceuticals, Inc. (Regeneron) - Immuno-Oncology Agreement - Additional Information (Detail)
Alliance Arrangements With Regeneron Pharmaceuticals, Inc. (Regeneron) - Investment Agreement - Additional Information (Detail)
Assets Held For Sale Or Exchange And Liabilities Related To Assets Held For Sale Or Exchange
Assets Held For Sale Or Exchange And Liabilities Related To Assets Held For Sale Or Exchange (Tables)
Assets Held For Sale Or Exchange And Liabilities Related To Assets Held For Sale Or Exchange - Summary Of Assets Held For Sale Or Exchange, And Liabilities Related To Assets Held For Sale Or Exchange (Detail)
Attributable To Non-Controlling Interests
Cash And Cash Equivalents
Cash And Cash Equivalents (Tables)
Cash And Cash Equivalents - Summary Of Cash And Cash Equivalents (Detail)
Cash And Cash Equivalents - Summary Of Cash And Cash Equivalents (Parenthetical) (Detail)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments (Tables)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments - Additional Information (Detail)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments - Summary Of Assets And Liabilities Divested (Detail)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments - Summary Of Changes In Equity Interest Held (Detail)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments - Summary Of Final Purchase Price Allocation (Detail)
Changes In The Scope Of Consolidation Due To Acquisitions And Divestments - Summary Of Purchase Price Allocation (Detail)
Consolidated Shareholder's Equity - Summary Of Expenses (Detail)
Consolidated Shareholder's Equity - Summary Of Number Of Restricted Shares Not Yet Fully Vested (Detail)
Consolidated Shareholder's Equity - Summary Of Repurchases Program (Detail)
Consolidated Shareholders' Equity
Consolidated Shareholders' Equity (Tables)
Consolidated Shareholders' Equity - Additional Information (Detail)
Consolidated Shareholders' Equity - Disclosure Of Stock Subscription Option Plan Outstanding And Option Exercised (Detail)
Consolidated Shareholders' Equity - Principal Characteristics Of Restricted Share Plans (Detail)
Consolidated Shareholders' Equity - Summary Of Characteristics Of Employee Share Ownership Plans Awarded (Detail)
Consolidated Shareholders' Equity - Summary Of Characteristics Of Employee Share Ownership Plans Awarded (Parenthetical) (Detail)
Consolidated Shareholders' Equity - Summary Of Currency Translation Differences (Detail)
Consolidated Shareholders' Equity - Summary Of Expense Recognized Through Equity For Stock Option Plans (Detail)
Consolidated Shareholders' Equity - Summary Of Movements Share Capital (Detail)
Consolidated Shareholders' Equity - Summary Of Movements Within Other Comprehensive Income (Detail)
Consolidated Shareholders' Equity - Summary Of Movements Within Other Comprehensive Income (Parenthetical) (Detail)
Consolidated Shareholders' Equity - Summary Of Number Of Shares Used To Compute Diluted Earnings Per Share (Detail)
Consolidated Shareholders' Equity - Summary Of Options Outstanding And Exercisable (Detail)
Consolidated Shareholders' Equity - Summary Of Stock Option Plans Awarded And Measurement Of Stock Option Plans (Detail)
Consolidated Shareholders' Equity - Summary Of Stock Options Outstanding At Each Balance Sheet Date (Detail)
Consolidated Shareholders' Equity - Summary Of Stock Purchase Option Plan Still Outstanding (Detail)
Consolidated Shareholders' Equity - Summary Of Treasury Shares Held (Detail)
Debt, Cash And Cash Equivalents
Debt, Cash And Cash Equivalents (Tables)
Debt, Cash And Cash Equivalents - Additional Information (Detail)
Debt, Cash And Cash Equivalents - Amount Of Future Undiscounted Contractual Cash Flows Relating To Debt And Derivative Instruments Designated As Hedges Of Debt (Detail)
Debt, Cash And Cash Equivalents - Disclosure Of Movement In Total Debt (Detail)
Debt, Cash And Cash Equivalents - Summary Of Bond Issues (Detail)
Debt, Cash And Cash Equivalents - Summary Of Changes In Financial Position (Detail)
Debt, Cash And Cash Equivalents - Summary Of Debt By Currency (Detail)
Debt, Cash And Cash Equivalents - Summary Of Debt By Interest Rate (Detail)
Debt, Cash And Cash Equivalents - Summary Of Debt By Maturity At Value On Redemption (Detail)
Debt, Cash And Cash Equivalents - Summary Of Interest Rate Fluctuations Of Debt Net Of Cash And Cash Equivalents (Detail)
Debt, Cash And Cash Equivalents - Summary Of Interest Rate Of Net Debt At Value On Redemption (Detail)
Debt, Cash And Cash Equivalents - Summary Of Market Value Of Net Debt (Detail)
Debt, Cash And Cash Equivalents - Summary Of Net Debt By Type Valuation Of Redemption (Detail)
Debt, Cash And Cash Equivalents - Summary Of Reconciliation Of Carrying Amount To Value On Redemption (Detail)
Derivative Financial Instruments And Market Risks
Derivative Financial Instruments And Market Risks (Tables)
Derivative Financial Instruments And Market Risks - Additional Information (Detail)
Derivative Financial Instruments And Market Risks - Disclosure Of Actual Or Potential Effects Of Netting Arrangements (Detail)
Derivative Financial Instruments And Market Risks - Disclosure Of Financial Currency Hedging Instruments In Place With Notional Amount Translated (Detail)
Derivative Financial Instruments And Market Risks - Disclosure Of Financial Currency Hedging Instruments In Place With Notional Amount Translated (Parenthetical) (Detail)
Derivative Financial Instruments And Market Risks - Disclosure Of Instruments (Detail)
Derivative Financial Instruments And Market Risks - Summary Of Fair Value Of Derivative Instruments (Detail)
Derivative Financial Instruments And Market Risks - Summary Of Operating Currency Hedging Instruments (Detail)
Disclosures About Major Customers And Credit Risk
Disclosures About Major Customers And Credit Risk - Additional Information (Detail)
Events Subsequent To December 31, 2018
Exchange Of The Animal Health Business
Exchange Of The Animal Health Business - Additional Information (Detail)
Exchanged/Held-For-Exchange Animal Health Business
Exchanged/Held-For-Exchange Animal Health Business (Tables)
Exchanged/Held-For-Exchange Animal Health Business - Additional Information (Detail)
Exchanged/Held-For-Exchange Animal Health Business - Summary Of Assets And Liabilities Held For Sale Or Exchange (Detail)
Exchanged/Held-For-Exchange Animal Health Business - Summary Of Basic And Diluted Earnings Per Share For Held-For-Exchange Animal Health Business (Detail)
Exchanged/Held-For-Exchange Animal Health Business - Summary Of Main Items Included In Net Income/(Loss) Of Held-For-Exchange Animal Health Business (Detail)
Exchanged/Held-For-Exchange Animal Health Business - Summary Of Main Items Included In Net Income/(Loss) Of Held-For-Exchange Animal Health Business (Parenthetical) (Detail)
Financial Assets And Liabilities Measured At Fair Value
Financial Assets And Liabilities Measured At Fair Value (Tables)
Financial Assets And Liabilities Measured At Fair Value - Additional Information (Detail)
Financial Assets And Liabilities Measured At Fair Value - Summary Of Assets And Liabilities Measured At Fair Value (Detail)
Financial Expenses And Income
Financial Expenses And Income (Tables)
Financial Expenses And Income - Summary Of Analysis Of Financial Income And Expenses (Detail)
Financial Expenses And Income - Summary Of Analysis Of Financial Income And Expenses (Parenthetical) (Detail)
Goodwill And Other Intangible Assets
Goodwill And Other Intangible Assets (Tables)
Goodwill And Other Intangible Assets - Additional Information (Detail)
Goodwill And Other Intangible Assets - Amortization Of Softwares Recognized In Income Statement (Detail)
Goodwill And Other Intangible Assets - Detailed Information For Principal Marketed Products (Detail)
Goodwill And Other Intangible Assets - Detailed Information For Principal Marketed Products (Parenthetical) (Detail)
Goodwill And Other Intangible Assets - Schedule Of Movements In Goodwill (Detail)
Goodwill And Other Intangible Assets - Schedule Of Movements In Other Intangible Assets (Detail)
Hyperinflation
Hyperinflation - Translation Of Financial Statements - Additional Information (Detail)
Impairment Of Intangible Assets And Property, Plant And Equipment
Impairment Of Intangible Assets And Property, Plant And Equipment (Tables)
Impairment Of Intangible Assets And Property, Plant And Equipment - Additional Information (Detail)
Impairment Of Intangible Assets And Property, Plant And Equipment - Schedule Of Allocation Of Goodwill (Detail)
Impairment Of Intangible Assets And Property, Plant And Equipment -Summary Of Net Impairment Losses Of Other Intangible Assets (Detail)
Impairment Of Intangible Assets And Property, Plant And Equipment -Summary Of Net Impairment Losses Of Other Intangible Assets (Parenthetical) (Detail)
Income Tax Expense
Income Tax Expense (Tables)
Income Tax Expense - Summary Of Allocation Of Income Tax Expense Between Current And Deferred Taxes (Detail)
Income Tax Expense - Summary Of Difference Between Effective Tax Rate And Standard Corporate Income Tax Rate (Detail)
Income Tax Expense - Summary Of Difference Between Effective Tax Rate And Standard Corporate Income Tax Rate (Parenthetical) (Detail)
International Financial Reporting Standards (Ifrs)
Inventories
Inventories (Tables)
Inventories - Additional Information (Detail)
Inventories - Schedule Of Inventories (Detail)
Investments Accounted For Using The Equity Method
Investments Accounted For Using The Equity Method (Tables)
Investments In Associates And Joint Ventures - Additional Information (Detail)
Investments In Associates And Joint Ventures - Summary Of Financial Statements Of Regeneron, After Adjustments To Comply With Ifrs But Before Fair Value Remeasurements (Detail)
Investments In Associates And Joint Ventures - Summary Of Investments In Associates And Joint Ventures (Detail)
Investments In Associates And Joint Ventures - Summary Of Principal Transactions And Balances With Related Parties (Detail)
Investments In Associates And Joint Ventures - Summary Of Reconciliation To Carrying Amount Of Investment (Detail)
Investments In Associates And Joint Ventures - Summary Of Share Of Profit Or Loss And Other Comprehensive Income Of Associates And Joint Ventures (Detail)
Investments In Associates And Joint Ventures -Summary Of Market Value Of Sanofi's Investment In Regeneron Based On Quoted Stock Market Price Per Share (Detail)
Legal And Arbitral Proceedings
Legal And Arbitral Proceedings - Additional Information (Detail)
Liabilities Related To Business Combinations And To Non-Controlling Interests
Liabilities Related To Business Combinations And To Non-Controlling Interests (Tables)
Liabilities Related To Business Combinations And To Non-Controlling Interests - Additional Information (Detail)
Liabilities Related To Business Combinations And To Non-Controlling Interests - Summary Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-Controlling Interests (Detail)
Liabilities Related To Business Combinations And To Non-Controlling Interests - Summary Of Maximum Amount Of Contingent Consideration Payable And Firm Commitments To Buy Out Non-Controlling Interests (Parenthetical) (Detail)
Liabilities Related To Business Combinations And To Non-Controlling Interests - Summary Of Movements In Liabilities Related To Business Combinations And To Non-Controlling Interests (Detail)
Liabilities Related To Business Combinations And To Non-Controlling Interests - Summary Of Movements In Liabilities Related To Business Combinations And To Non-Controlling Interests (Parenthetical) (Detail)
List Of Principal Companies Included In The Consolidation Scope During 2018
List Of Principal Companies Included In The Consolidation Scope During 2018 (Tables)
Net Deferred Tax Position
Net Deferred Tax Position (Tables)
Net Deferred Tax Position - Additional Information (Detail)
Net Deferred Tax Position - Summary Of Net Deferred Tax Position (Detail)
Net Deferred Tax Position - Summary Of Net Deferred Tax Position (Parenthetical) (Detail)
Net Deferred Tax Position - Summary Of Tax Losses Available For Carry-Forward (Detail)
Net Deferred Tax Position - Summary Of Tax Losses Available For Carry-Forward (Parenthetical) (Detail)
Net Income Attributable To Non-Controlling Interests
Net Income Attributable To Non-Controlling Interests (Tables)
Net Income Attributable To Non-Controlling Interests - Summary Of Trends In Net Income Attributable To Non-Controlling Interests (Detail)
New Standards, Amendments And Interpretations
New Standards, Amendments And Interpretations (Tables)
New Standards, Amendments And Interpretations - Additional Information (Detail)
New Standards, Amendments And Interpretations - Summary Of Impacts On Consolidated Balance Sheet (Detail)
New Standards, Amendments And Interpretations - Summary Of Impacts On Consolidated Income Statement (Detail)
New Standards, Amendments And Interpretations - Summary Of Reclassification And Impacts Of Financial Assets (Detail)
Notes To The Consolidated Financial Statements
Off Balance Sheet Commitments
Off Balance Sheet Commitments (Tables)
Off Balance Sheet Commitments - Summary Of Future Minimum Lease Payments Due Under Non-Cancelable Leases And Rental Expense (Detail)
Off-Balance Sheet Commitments - Additional Information (Detail)
Off-Balance Sheet Commitments - Summary Of Amount Of Guarantees Given And Received (Detail)
Off-Balance Sheet Commitments - Summary Of Off Balance Sheet Commitments Relating To Operating Activities (Detail)
Off-Balance Sheet Commitments - Summary Of Off Balance Sheet Commitments Relating To Operating Activities (Parenthetical) (Detail)
Off-Balance Sheet Commitments - Summary Of Undrawn Credit Facilities (Detail)
Other Current Assets
Other Current Assets (Tables)
Other Current Assets - Schedule Of Other Current Assets (Detail)
Other Gains And Losses, And Litigation
Other Gains And Losses, And Litigation - Additional Information (Detail)
Other Non-Current Assets
Other Non-Current Assets (Tables)
Other Non-Current Assets - Additional Information (Detail)
Other Non-Current Assets - Summary Of Other Non-Current Assets (Detail)
Other Operating Expenses
Other Operating Expenses - Additional Information (Detail)
Other Operating Income
Other Operating Income - Additional Information (Detail)
Personnel Costs
Personnel Costs (Tables)
Personnel Costs - Additional Information (Detail)
Personnel Costs - Summary Of Employee Numbers By Function (Detail)
Personnel Costs - Summary Of Employee Numbers By Function (Parenthetical) (Detail)
Personnel Costs - Summary Of Personal Costs (Detail)
Personnel Costs - Summary Of Personal Costs (Parenthetical) (Detail)
Principal Accountants' Fees And Services
Principal Accountants' Fees And Services (Tables)
Principal Accountants' Fees And Services - Disclosure Of Accountants' Fees And Services (Detail)
Principal Accountants' Fees And Services - Disclosure Of Accountants' Fees And Services (Parenthetical) (Detail)
Principal Alliances
Principal Associates And Joint Ventures - Summary Of Principal Investments Accounted For Using The Equity Method (Detail)
Principal Fully Consolidated Companies - Summary Of Principal Companies And Their Country Of Incorporation (Detail)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Schedule Of Amounts For Items Of Property, Plant And Equipment Held Under Finance Leases (Detail)
Property, Plant And Equipment - Schedule Of Future Minimum Lease Payment Schedule (Detail)
Property, Plant And Equipment - Schedule Of Property, Plant And Equipment (Including Assets Held Under Finance Leases) (Detail)
Property, Plant And Equipment - Summary Of Acquisitions And Capitalized Interest By Operating Segment (Detail)
Property, Plant And Equipment - Summary Of Future Minimum Lease Payments Due Under Finance Lease (Detail)
Property, Plant And Equipment - Summary Of Impairment Losses Recognised In Property, Plant And Equipment (Detail)
Property, Plant And Equipment - Summary Of Off Balance Sheet Commitments Relating To Property, Plant And Equipment (Detail)
Provision And Other Liabilities - Other Non-Current Liabilities (Detail)
Provision And Other Liabilities - Other Non-Current Liabilities (Parenthetical) (Detail)
Provisions And Other Liabilities
Provisions And Other Liabilities (Tables)
Provisions And Other Liabilities - Additional Information (Detail)
Provisions And Other Liabilities - Current Provisions And Other Current Liabilities (Detail)
Provisions And Other Liabilities - Estimated Amounts Of Employer's Contributions To Plan Assets (Detail)
Provisions And Other Liabilities - Expected Timing Of Benefit Payments Under Pension And Other Post-Employment Benefit Plans (Detail)
Provisions And Other Liabilities - Fair Value Of Plans Assets Relating To Pension Plans And Other Post-Employment Plans (Detail)
Provisions And Other Liabilities - Movements In Restructuring Provisions Classified In Non-Current And Current Liabilities (Detail)
Provisions And Other Liabilities - Net Amount Recognized In Respect Of Pension And Other Post-Employment Benefit Plans (Detail)
Provisions And Other Liabilities - Net Liability In Respect Of Pension Plans And Other Post-Employment Benefits By Geographical Region (Detail)
Provisions And Other Liabilities - Remeasurement Of Net Defined-Benefit (Asset)/Liability (Actuarial Gains And Losses) (Detail)
Provisions And Other Liabilities - Service Cost For Pension And Other Post-Employment Benefit Plans, By Geographical Region (Detail)
Provisions And Other Liabilities - Summary Of Movements In Non-Current Provisions (Detail)
Provisions And Other Liabilities - Summary Of Net Pre-Tax Actuarial Loss (Detail)
Provisions And Other Liabilities - Summary Of Non Current Provisions And Other Non-Current Liabilities (Detail)
Provisions And Other Liabilities - Summary Of Other Provisions (Detail)
Provisions And Other Liabilities - Summary Of Present Value Of Pension And Other Post Employement Benefits (Detail)
Provisions And Other Liabilities - Summary Of Sensitivity For Pensions And Other Post-Employment Benefits To Changes In Key Actuarial Assumptions (Detail)
Provisions And Other Liabilities - Summary Of Weighted Average Duration Of Obligation For Pensions And Other Long-Term Benefits In Principal Countries (Detail)
Provisions And Other Liabilities - Timing Of Future Payments In Respect Of Unfunded Pension And Other Post-Employment Benefit Plans (Detail)
Provisions And Other Liabilities - Timing Of Future Termination Benefit Payments (Detail)
Provisions And Other Liabilities - Total Expense For Pensions And Other Post-Employment Benefits Allocated Between Income Statement (Detail)
Provisions And Other Non-Current Liabilities - Summary Of Financial And Demographic Assumptions (Detail)
Provisions And Other Non-Current Liabilities - Summary Of Financial And Demographic Assumptions (Parenthetical) (Detail)
Provisions For Discounts, Rebates And Sales Returns
Provisions For Discounts, Rebates And Sales Returns (Tables)
Provisions For Discounts, Rebates And Sales Returns - Summary Of Movement In Provisions For Discounts, Rebates And Sales Returns (Detail)
Provisions For Discounts, Rebates And Sales Returns - Summary Of Movement In Provisions For Discounts, Rebates And Sales Returns (Parenthetical) (Detail)
Related Party Transactions
Related Party Transactions (Tables)
Related Party Transactions - Additional Information (Detail)
Related Party Transactions - Schedule Of Compensation Paid To Key Management Personnel (Detail)
Related Party Transactions - Summary Of Aggregate Amounts Payable To Key Management Personnel (Detail)
Restructuring Costs And Similar Items
Restructuring Costs And Similar Items (Tables)
Restructuring Costs And Similar Items - Additional Information (Detail)
Restructuring Costs And Similar Items - Summary Of Restructuring Costs And Similar Items (Detail)
Segment Information
Segment Information (Tables)
Segment Information - Additional Information (Detail)
Segment Information - Schedule Of Acquisition Of Intangible Assets, Property, Plant And Equipment And Investments Accounted For Using The Equity Method By Segment (Detail)
Segment Information - Schedule Of Reconciliation Between Business Operating Income For The Segments And Income Before Tax And Investments Accounted For Using The Equity Method (Detail)
Segment Information - Schedule Of Reconciliation Between Business Operating Income For The Segments And Income Before Tax And Investments Accounted For Using The Equity Method (Parenthetical) (Detail)
Segment Information - Schedule Of Segment Results (Detail)
Segment Information - Schedule Of Segment Results (Parenthetical) (Detail)
Segment Information - Summary Of Geographical Information On Net Sales And Non-Current Assets (Detail)
Segment Information - Summary Of Net Sales By Segment And Geographical Area (Detail)
Share Of Profit Loss From Investments Accounted For Using The Equity Method
Share Of Profit Loss From Investments Accounted For Using The Equity Method (Tables)
Share Of Profit/Loss Of Investments Accounted For Using The Equity Method - Additional Information (Detail)
Share Of Profit/Loss Of Investments Accounted For Using The Equity Method - Summary Of Analysis Of Share Of Profit/Loss From Investments Accounted For Using Equity Method (Detail)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Employee Benefit Obligations - Additional Information (Detail)
Summary Of Significant Accounting Policies - Income Tax Expense - Additional Information (Detail)
Summary Of Significant Accounting Policies - Other Intangible Assets Not Acquired In Business Combination - Additional Information (Detail)
Summary Of Significant Accounting Policies - Provision For Risks - Additional Information (Detail)
Summary Of Significant Accounting Policies - Segment Information - Additional Information (Detail)
Summary Of Significant Accounting Policies - Share-Based Payment - Additional Information (Detail)
Summary Of Significant Accounting Policies - Summary Of Useful Lives Of Property Plant And Equipment (Detail)
Summary Of Significant Accounting Policies - Treasury Shares - Additional Information (Detail)
Use Of Estimates And Judgments
Withdrawal Of The United Kingdom From The European Union
Ticker: SNY
CIK: 1121404
Form Type: 20-F Annual Report
Accession Number: 0001193125-19-068926
Submitted to the SEC: Fri Mar 08 2019 2:30:32 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Monday, December 31, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/sny/0001193125-19-068926.htm